TMHC stock icon

Taylor Morrison
TMHC

$64.37
1.41%

Market Cap: 6.81B

 

About: Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West and Financial Services. The majority of the company's revenue is derived from its East Segment.

Employees: 2,900

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 6 analysts
0
News positive %
of 5 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

283% more call options, than puts

Call options by funds: $3.57M | Put options by funds: $933K

33% more funds holding in top 10

Funds holding in top 10: 3 [Q4 2023] → 4 (+1) [Q1 2024]

17% more capital invested

Capital invested by funds: $5.4B [Q4 2023] → $6.32B (+$920M) [Q1 2024]

1.37% more ownership

Funds ownership: 94.15% [Q4 2023] → 95.52% (+1.37%) [Q1 2024]

0% less funds holding

Funds holding: 363 [Q4 2023] → 362 (-1) [Q1 2024]

2% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 52

9% less repeat investments, than reductions

Existing positions increased: 124 | Existing positions reduced: 137

Research analyst outlook

6 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$55
15%
downside
Avg. target
$60
6%
downside
High target
$63
2%
downside

6 analyst ratings

positive
33%
neutral
67%
negative
0%
Barclays
Matthew Bouley
4%downside
$62
Equal-Weight
Maintained
12 Jul 2024
RBC Capital
Mike Dahl
2%downside
$63
Outperform
Maintained
1 May 2024
Wedbush
Jay McCanless
5%downside
$61
Neutral
Maintained
1 May 2024
Wedbush
Jay McCanless
15%downside
$55
Neutral
Reiterated
30 Apr 2024
RBC Capital
Mike Dahl
5%downside
$61
Outperform
Maintained
15 Feb 2024

Financial journalist opinion

Based on 5 articles about TMHC published over the past 30 days